Alexion Pharmaceuticals Inc. (ALXN) Climbed 14.5% or 15.38 To Price $121.42 On Thursday


Alexion Pharmaceuticals Inc. (ALXN) climbed 14.5% or 15.38 to $121.42. It is approximately 5.79 million shares traded, which is 242.74% compare to the average total volume 2.39 million. The market cap of ALXN is $27.00 billion. The year to date change is -14.52%. The 52 week price range is from $96.18 to $149.34. Price of ALXN have changed -5.10% during last week. It have changed -4.94% over last month, -17.21% over last 3 months, -15.89% over last 6 months and -12.17% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ALXN is 115.45. It is -4.92% below current price. The 200-day Moving Averages for ALXN is 124.52. It is 2.55% above current price. The 52-week High is 149.34. It is 22.99% from the current price. The 52-week Low is 96.18. It is -20.79% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ALXN is 1.79 on 2018-04-13. Short % to float is 2.08%. There are some statistics of ALXN. It is has market cap $27.00 billion. The share outstanding is 222.36 million. The average volume is 2.39 million. The revenue is 3.55B. It has 5.91B cash and 13.03B in debt. The gross profit is 3.10B. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ALXN is 4.71%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ALXN is 3.09%.


Tags:

Share this post